# Everest Biolabs, Inc. — Form D

Everest Biolabs, Inc. of WALTHAM, MA, a company, filed a Form D exempt-offering notice with the SEC on 2026-03-11. The offering totals $5.7M, of which $4.3M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2026-03-11
- Form: D
- Accession: 0002116676-26-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.7M
- Amount sold: $4.3M
- Remaining: $1.3M
- Investors: 7
- Date of first sale: 2026-02-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-576080

## Issuer

- Name: Everest Biolabs, Inc.
- CIK: 0002116676
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 204 SECOND AVE, WALTHAM, MA, 02451
- Phone: 6172140840

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| GEORGE DAABOUL | Director | Waltham, MA |
| DAVID FREEDMAN | Director | Waltham, MA |
| Paul Meister | Director | Waltham, MA |
| Vinit Nijhawan | Director | Waltham, MA |
| David Walt | Director | Cambridge, MA |
| GEORGE DAABOUL | Executive Officer | Waltham, MA |
| DAVID FREEDMAN | Executive Officer | Waltham, MA |

## More

- [CIK 2116676 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2116676&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002116676-26-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.